SciCombinator

Discover the most talked about and latest scientific content & concepts.

TRAIL-coated leukocytes that kill cancer cells in the circulation

OPEN Proceedings of the National Academy of Sciences of the United States of America | 8 Jan 2014

MJ Mitchell, E Wayne, K Rana, CB Schaffer and MR King
Abstract
Metastasis through the bloodstream contributes to poor prognosis in many types of cancer. Mounting evidence implicates selectin-based adhesive interactions between cancer cells and the blood vessel wall as facilitating this process, in a manner similar to leukocyte trafficking during inflammation. Here, we describe a unique approach to target and kill colon and prostate cancer cells in the blood that causes circulating leukocytes to present the cancer-specific TNF-related apoptosis inducing ligand (TRAIL) on their surface along with E-selectin adhesion receptor. This approach, demonstrated in vitro with human blood and also in mice, mimics the cytotoxic activity of natural killer cells and increases the surface area available for delivery of the receptor-mediated signal. The resulting “unnatural killer cells” hold promise as an effective means to neutralize circulating tumor cells that enter blood with the potential to form new metastases.
Tweets*
70
Facebook likes*
2
Reddit*
2
News coverage*
21
Blogs*
6
SC clicks
4
Concepts
Metastasis, Oncology, Lymphocyte, Blood vessel, Prostate cancer, Blood, Cancer, Immune system
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com